Life Sciences

Despite a slower than expected quarter, ReWalk Robotics of Marlborough saw a revenue jump of more than 20 percent, but declared a $5.8 million loss as the manufacturer of robotic exoskeletons for spinal cord-injury victims seeks more customers.

Oxford Immunotec, a diagnostics company with U.S. headquarters in Marlborough, announced revenue growth in the second quarter of 2015 alongside continued overall losses.

A 2.3-percent tax doesn't sound like much, but taking it directly off the top of medical device companies' sales could have widespread impacts on businesses large and small, industry experts say.

The brainpower at Central Massachusetts life sciences startup companies is remarkable. But are brains synonymous with business savvy?

Citing spotty hiring and a delay in a Brazilian drug-testing law, Pschemedics Corp. of Acton said net income for the second quarter declined 71 percent, to $252,000, or 5 cents a share. It was $857,000, or 16 cents per share, in the year-earlier quarter.

<i>(UPDATED Friday, July 31 to correct company name)</i> Holliston-based Harvard Bioscience reported Thursday that the second quarter of 2015 saw revenue rise to $28.8 million.

Marlborough-based Boston Scientific saw its operational revenue and profits rise in the second quarter, the company reported Thursday. The results are at the upper end of the company's guidance range.

On the heels of news that global pharmaceutical giant Pfizer plans to consolidate its local operations into a 500,000 square foot campus for about 1,000 employees in Cambridge, industry executives gathered Wednesday to discuss the biotech real estate boom and its impact on commercial real estate trends in the state.

Since insulin became the first treatment available in the 1970s, the biologics field has exploded.

Ocata Therapeutics of Marlborough has secured another patent for its technology aimed at treating some forms of macular degeneration, the company announced last week.